Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 206

Similar articles for PubMed (Select 9009654)

1.

Clinical use of oral nystatin in the prevention of systemic candidosis in patients at particular risk.

Schäfer-Korting M, Blechschmidt J, Korting HC.

Mycoses. 1996 Sep-Oct;39(9-10):329-39. Review.

PMID:
9009654
2.

A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.

Patton LL, Bonito AJ, Shugars DA.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Aug;92(2):170-9.

PMID:
11505264
3.
4.

Treatment of oropharyngeal candidiasis in HIV-positive patients.

Greenspan D.

J Am Acad Dermatol. 1994 Sep;31(3 Pt 2):S51-5. Review.

PMID:
7915732
5.

Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis.

Ellepola AN, Samaranayake LP.

Dent Update. 2000 May;27(4):165-70, 172-4. Review.

PMID:
11218451
6.

Fluconazole versus nystatin in the prevention of candida infections in children and adolescents undergoing remission induction or consolidation chemotherapy for cancer.

Groll AH, Just-Nuebling G, Kurz M, Mueller C, Nowak-Goettl U, Schwabe D, Shah PM, Kornhuber B.

J Antimicrob Chemother. 1997 Dec;40(6):855-62.

7.

Antifungal prophylaxis in immunocompromised hosts.

Reents S, Goodwin SD, Singh V.

Ann Pharmacother. 1993 Jan;27(1):53-60. Review.

PMID:
8431623
8.

Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions.

Pons V, Greenspan D, Lozada-Nur F, McPhail L, Gallant JE, Tunkel A, Johnson CC, McCarty J, Panzer H, Levenstein M, Barranco A, Green S.

Clin Infect Dis. 1997 Jun;24(6):1204-7.

9.

Fluconazole versus nystatin in the treatment of oral candidosis.

Blomgren J, Berggren U, Jontell M.

Acta Odontol Scand. 1998 Aug;56(4):202-5.

PMID:
9765010
10.

Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation.

Lumbreras C, Cuervas-Mons V, Jara P, del Palacio A, Turrión VS, Barrios C, Moreno E, Noriega AR, Paya CV.

J Infect Dis. 1996 Sep;174(3):583-8.

11.

The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus.

Willis AM, Coulter WA, Fulton CR, Hayes JR, Bell PM, Lamey PJ.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Mar;91(3):317-21.

PMID:
11250629
12.

Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing?

Isaacs D.

Curr Opin Infect Dis. 2008 Jun;21(3):246-50. doi: 10.1097/QCO.0b013e3282f8adab. Review.

PMID:
18448968
13.

Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata.

White DJ, Johnson EM, Warnock DW.

Genitourin Med. 1993 Apr;69(2):112-4.

14.
15.
16.

Antifungal topical therapy in oral chronic candidosis. A comparative study.

Lopez-De-Blanc SA, Salati-De-Mugnolo N, Femopase FL, Benitez MB, Morelatto RA, Astrada-De-Verde L, Masih D.

Med Oral. 2002 Jul-Oct;7(4):260-70. English, Spanish.

17.

Nystatin pastilles and suspension in the treatment of oral candidosis.

Millns B, Martin MV.

Br Dent J. 1996 Sep 21;181(6):209-11.

PMID:
8885454
18.

Oral candidal infections and antimycotics.

Ellepola AN, Samaranayake LP.

Crit Rev Oral Biol Med. 2000;11(2):172-98. Review.

20.

Value of antifungal prophylaxis with antifungal drugs against oropharyngeal candidiasis in cancer patients.

Meunier F, Paesmans M, Autier P.

Eur J Cancer B Oral Oncol. 1994 May;30B(3):196-9.

PMID:
7920166
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk